A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the degree of additional reduction in
cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently
accepted minimum target level for patients with pre-existing CHD. Secondary objectives
include the safety profile of this treatment strategy, its cost-effectiveness, effect on
other atherosclerotic-related events and procedures, and total mortality.